AirSculpt Technologies, Inc. (NASDAQ:AIRS) Q1 2024 Earnings Overview
- AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported an EPS of $0.1032, surpassing the estimated EPS of $0.08.
- AirSculpt Technologies demonstrated a 4% year-over-year revenue increase to $47.62 million, despite falling short of the Zacks Consensus Estimate.
- AirSculpt Technologies demonstrated strong operational performance with a net income of $6.029 million, an operating income of $11.012 million, and an EBITDA of $29.054 million, reflecting solid financial health.
AirSculpt Technologies, Inc. (NASDAQ:AIRS), a company known for its innovative approach in the technology services industry, recently disclosed its financial performance for the first quarter of 2024. On May 10, 2024, AIRS reported an earnings per share (EPS) of $0.1032, surpassing the estimated EPS of $0.08, indicating a positive outcome in terms of profitability. However, the company's revenue for the quarter was $47.62 million, which did not meet the expected $49.8 million, showcasing a challenge in reaching anticipated sales figures.
During the earnings conference call, led by key figures such as CFO Dennis Dean and CEO Todd Magazine, AIRS provided insights into its financial health and operational achievements. Despite the revenue shortfall, the company demonstrated a 4% year-over-year increase in revenue, from $45.81 million the previous year to $47.62 million. This growth, although positive, fell short of the Zacks Consensus Estimate of $50.06 million, resulting in a -4.88% surprise. The detailed discussion in the call, available on Seeking Alpha, offered stakeholders a chance to directly engage with the company's leadership, highlighting AIRS's commitment to transparency and communication with its investors.
The earnings report also revealed a significant decrease in EPS from $0.10 a year ago to $0.03 for the quarter, missing the consensus estimate of $0.08 by a wide margin. This -62.50% EPS surprise marks a continuation of AIRS's struggle to surpass consensus EPS estimates over the last four quarters. Such a trend underscores the importance of not only tracking year-over-year changes but also comparing these figures against Wall Street expectations to better understand the stock's potential trajectory.
Financially, AIRS showcased a robust operational performance with a net income of $6.029 million and an operating income of $11.012 million. The company's EBITDA stood at $29.054 million, reflecting its operational efficiency and profitability before interest, taxes, depreciation, and amortization. Despite the revenue and EPS shortfall, these figures indicate solid underlying financial health, which could offer some reassurance to investors concerned about the missed estimates.
In summary, AirSculpt Technologies' first quarter of 2024 presented a mixed financial picture. While the company exceeded EPS expectations, it fell short on revenue forecasts, highlighting the challenges it faces in the competitive technology services industry. The detailed earnings call and subsequent financial analysis provide a comprehensive view of AIRS's current position and future prospects, offering valuable insights for investors and stakeholders.
| Symbol | Price | %chg |
|---|---|---|
| SILO.JK | 2500 | 0 |
| MIKA.JK | 2240 | 0 |
| SRAJ.JK | 2460 | 0 |
| HEAL.JK | 1060 | 0 |
AirSculpt Technologies, Inc. (NASDAQ:AIRS) Faces Financial Challenges Despite Revenue Resilience
- AirSculpt Technologies, Inc. (NASDAQ:AIRS) reported an EPS of -$0.09, missing estimates and indicating a decline in performance.
- The company achieved revenues of $39.18 million for the quarter, slightly above expectations but lower than the previous year.
- AIRS's financial metrics reveal challenges in profitability and liquidity, with a negative P/E ratio and a high debt-to-equity ratio.
AirSculpt Technologies, Inc. (NASDAQ:AIRS) is a prominent player in the body contouring industry, known for its innovative and minimally invasive procedures. The company operates 32 centers worldwide and has performed over 70,000 procedures. Despite its strong market presence, AIRS faces stiff competition from other cosmetic surgery providers. The company recently reported its financial results for the fourth quarter and full year ending December 31, 2024.
On March 14, 2025, AIRS announced an earnings per share (EPS) of -$0.09, missing the estimated EPS of $0.02. This represents a significant earnings surprise of -500%, as highlighted by Zacks. The company had previously reported earnings of $0.01 per share in the same quarter last year, indicating a decline in performance. Over the past four quarters, AIRS has consistently failed to meet consensus EPS estimates, raising concerns about its financial health.
Despite the earnings miss, AIRS reported revenues of $39.18 million for the quarter, slightly exceeding the Zacks Consensus Estimate by 0.48%. However, this is a decrease from the $47.61 million in revenue reported in the same quarter the previous year. The company has managed to surpass consensus revenue estimates twice in the last four quarters, showing some resilience in its revenue generation.
AIRS's financial metrics reveal challenges in profitability and liquidity. The company has a negative price-to-earnings (P/E) ratio of -21.76, indicating it is not currently profitable. The price-to-sales ratio is 0.90, suggesting the stock is valued at less than one times its sales. The enterprise value to sales ratio is 1.41, providing insight into the company's valuation relative to its revenue.
The company's debt-to-equity ratio stands at 1.24, indicating more debt than equity, which could pose financial risks. The current ratio is 0.51, suggesting potential liquidity challenges, as it indicates the company's ability to cover short-term liabilities with short-term assets. Despite these challenges, CEO Yogi Jashnani remains optimistic about the company's strategic planning and operational strategy to enhance shareholder value.
